Sponsor:
The University of Texas Health Science Center at San Antonio
Code:
NCT05960656
Conditions
Type 2 Diabetes
Type 1 Diabetes
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Empagliflozin 25 MG
Placebo
Pioglitazone 30mg
Pioglitazone 30mg + Empagliflozin (25 mg)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-16. This information was provided to ClinicalTrials.gov by The University of Texas Health Science Center at San Antonio on 2024-07-10.